XENE R&D to Revenue
Xenon Pharmaceuticals Inc · R&D to Revenue
XENE R&D to Revenue
Latest reported4012.51%period ending
XENE FY R&D/Revenue (177.83% → 4012.51%)
Latest values, visible window
High-resolution chart · PNG
XENE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4,012.5067% | |
| 0% | |
| 0% | |
| 1,121.1257% | |
| 409.3019% | |
| 157.0696% | |
| 568.8241% | |
| 0% | |
| 8,222.8296% | |
| 1,099.7227% | |
| 97.2716% | |
| 41.4804% | |
| 44.9737% | |
| 73.071% | |
| 177.826% |